Automated volumetric method fares well when compared to BI-RADS-based breast density

Radiological researchers in India have shown that a fully automated volumetric method can reliably provide accurate quantification of breast density.

Tulika Singh, MD, of the Post Graduate Institute of Medical Education and Research in the northern territory of Chandigarh, and colleagues found almost perfect agreement between this method and BI-RADS density categories as assigned by two radiologists.

Their study posted online Oct. 27 in Academic Radiology.

In the study, two blinded radiologists evaluated 476 full-field digital mammography exams with standard mediolateral oblique and craniocaudal views.

The two radiologists first assigned BI-RADS density categories, then used fully automated software marketed by New Zealand-based Volpara Solutions to calculate mean fibroglandular tissue volume, mean breast volume and mean volumetric breast density.

Assigning a volumetric density grade of 1 to 4, and basing the grade on percentage volumetric breast density, they achieved a weighted overall coefficient of 0.895—quite close to perfect—when correlating with their BI-RADS density estimates.

On visual assessment, less than a quarter of the study population was categorized as BI-RADS 3 or BI-RADS 4. Of the 476 exams, 444 (93.3 percent) showed agreement between BI-RADS grading of both the radiologists. In the 32 patients with disagreement, differences were within one category only.

Also, study authors recorded a significant difference between volumetric breast density of all BI-RADS categories, and noted that volumetric breast density increased with increased BI-RADS category.

The authors conclude that a fully automated volumetric method “could be used for quantification of breast density. However, further studies are required to evaluate the causes of disagreement between visual assessment and automated density measurement.” 

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.